Chamberlain JS - Search Results

1

Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.

Amalfitano A, Hauser MA, Hu H, Serra D, Begy CR, Chamberlain JS. Amalfitano A, et al. Among authors: chamberlain js. J Virol. 1998 Feb;72(2):926-33. doi: 10.1128/JVI.72.2.926-933.1998. J Virol. 1998. PMID: 9444984 Free PMC article.

2

Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy.

Amalfitano A, Chamberlain JS. Amalfitano A, et al. Among authors: chamberlain js. Gene Ther. 1997 Mar;4(3):258-63. doi: 10.1038/sj.gt.3300378. Gene Ther. 1997. PMID: 9135740

3

Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.

Hodges BL, Serra D, Hu H, Begy CA, Chamberlain JS, Amalfitano A. Hodges BL, et al. Among authors: chamberlain js. J Gene Med. 2000 Jul-Aug;2(4):250-9. doi: 10.1002/1521-2254(200007/08)2:4<250::AID-JGM113>3.0.CO;2-3. J Gene Med. 2000. PMID: 10953916

4

Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.

Amalfitano A, Begy CR, Chamberlain JS. Amalfitano A, et al. Among authors: chamberlain js. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3352-6. doi: 10.1073/pnas.93.8.3352. Proc Natl Acad Sci U S A. 1996. PMID: 8622940 Free PMC article.

5

Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase.

Hartigan-O'Connor D, Amalfitano A, Chamberlain JS. Hartigan-O'Connor D, et al. Among authors: chamberlain js. J Virol. 1999 Sep;73(9):7835-41. doi: 10.1128/JVI.73.9.7835-7841.1999. J Virol. 1999. PMID: 10438876 Free PMC article.

6

The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele.

Amalfitano A, Chamberlain JS. Amalfitano A, et al. Among authors: chamberlain js. Muscle Nerve. 1996 Dec;19(12):1549-53. doi: 10.1002/(SICI)1097-4598(199612)19:12<1549::AID-MUS4>3.0.CO;2-A. Muscle Nerve. 1996. PMID: 8941268 Free article.

7

Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy.

Hauser MA, Amalfitano A, Kumar-Singh R, Hauschka SD, Chamberlain JS. Hauser MA, et al. Among authors: chamberlain js. Neuromuscul Disord. 1997 Jul;7(5):277-83. doi: 10.1016/s0960-8966(97)00052-7. Neuromuscul Disord. 1997. PMID: 9267841

8

Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.

Ahmad A, Brinson M, Hodges BL, Chamberlain JS, Amalfitano A. Ahmad A, et al. Among authors: chamberlain js. Hum Mol Genet. 2000 Oct 12;9(17):2507-15. doi: 10.1093/hmg/9.17.2507. Hum Mol Genet. 2000. PMID: 11030755

9

Progress towards gene therapy for Duchenne muscular dystrophy.

Hauser MA, Chamberlain JS. Hauser MA, et al. Among authors: chamberlain js. J Endocrinol. 1996 Jun;149(3):373-8. doi: 10.1677/joe.0.1490373. J Endocrinol. 1996. PMID: 8691095 No abstract available.

10

Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.

Phelps SF, Hauser MA, Cole NM, Rafael JA, Hinkle RT, Faulkner JA, Chamberlain JS. Phelps SF, et al. Among authors: chamberlain js. Hum Mol Genet. 1995 Aug;4(8):1251-8. doi: 10.1093/hmg/4.8.1251. Hum Mol Genet. 1995. PMID: 7581361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters